Contracts › HT942523C0039
HT942523C0039: Medical & Research Development Contract for Dha Sttr Ph Ii A2-9110 Proposal Titled Ingestible Capsule for Vital Sign Monitoring.
Awarded to Nanohmics Inc by Defense Health Agency.
$1.1Mobligated
$1.1Mpotential value
02 November 2026current end date
See modifications, all subcontractors and funding in FedSift →
| Contract | HT942523C0039 |
|---|---|
| Awardee | Nanohmics Inc |
| Awarding agency | Defense Health Agency |
| Awarding office | ARMY MED RES ACQ ACTIVITY |
| NAICS | 541715 Research and Development in the Physical, Engineering, and Life Sciences (Except Nanotechnology and Biotechnology) |
| PSC | AN12 Health R&D Services; Health Care Services; Applied Research |
| Place of performance | TX |
| Offers received | 2 |
| Period of performance | 03 July 2023 to 02 November 2026 |
| Potential end | 02 November 2026 |
| Estimated recompete solicitation | Now / imminent (estimate, ~6 months before expiry) |
Source: USASpending.gov (FPDS), public federal procurement data, as the agency reported it. Our record updated 04 October 2026. The solicitation date is an estimate from the end date, not a posted date.
Other expiring 541715 contracts · All expiring contracts · USASpending record